Intelligence · Clinical Pipeline
PARItec Pipeline
All ClinicalTrials.gov programs at PARItec — phase, modality, and trial IDs.
- Programs
- 8
Quick answer
PARItec has 8 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
A Phase I/IIa Clinical Trial to Assess the Safety, Tolerability, and Efficacy of a Single Intravitreal Injection of SPVN20 Gene Therapy in Participants with Advanced Rod Cone Dystrophy
Pari Pharma GmbH
End-stage rod-cone dystrophy
1 trial -
CITY
Pari Pharma GmbH
Cutaneous T-cell lymphomas (CTCL)
1 trial -
Dose dense re-challenge of high dose methotrexate (hd-mtx) with glucarpidase (cpg2) for relapsed primary cns lymphoma (pcnsl): A phase 1 trial (METHOGLU)
Pari Pharma GmbH
Oncology: RELAPSED PRIMARY CNS LYMPHOMA
1 trial -
HTLP-onco-adult - A phase I/II Study evaluating the safety and the efficacy of Human T Lymphoid Progenitor (HTLP) injection to accelerate immune reconstitution after umbilical cord blood (UCB) transplantation in adult patients with hematologic malignancies
Pari Pharma GmbH
hematologic malignancies ; acute myeloid leukemias
1 trial -
In situ injection of anti-angiogenics in patients with brain arteriovenous malformations not eligible for exclusion treatment: phase I trial (BLITZ)
Pari Pharma GmbH
Cardiology and vascular disease
1 trial -
MUNC13.4-CD34 suspension, MUNC13.4-T3 suspension
Pari Pharma GmbH
Familial Hemophagocytic Lymphohistiocytosis (FHL)
1 trial -
SECRET-HF: Treatment of Non-ischemic Dilated Cardiomyopathies by Intravenous Infusions of the Extracellular Vesicle-Enriched Secretome of Cardiovascular Progenitor Cells
Pari Pharma GmbH
Non-ischemic Dilated Cardiomyopathies
1 trial -
Single-center, single-dose, open-label, laboratory-blinded, randomized, two-treatment, two-period bioequivalence (BE) study comparing the Test Product Apixaban 5 mg film-coated tablets (MEDITOP) with the Reference Product Eliquis 5 mg film-coated tablets (Bristol-Myers Squibb/Pfizer) under fasting conditions.
Pari Pharma GmbH
Comparative bioequivalence study in healthy volunteers under fasting conditions.
1 trial
Frequently asked questions
How many pipeline programs does PARItec have?
8 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs